glp 1 agonists and depression GLP-1 Receptor in Mood Disorders: A Psychiatric Perspective Insights into a possible role

Iorio and the other anonymous reviewer(s) for their contribution to the peer review of this work

Schachter, F

Published studies have demonstrated that MT-1 administration in research settings shifts the eumelanin-to-pheomelanin ratio, providing researchers with a tool to investigate the biological differences between these melanin subtypes (Brenner & Hearing, 2008)

CRP binding to oxLDL and apoptotic cells occurs through phosphorylcholine, and binding to this ligand starts phagocytosis (100, 170, 175181)

Medications like beta-blockers, calcium channel blockers, and digoxin are common culprits, along with electrolyte imbalances involving potassium, magnesium, or calcium